MedTrace Logo

A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation

NCT00184249 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-03-20

No results posted yet for this study

Summary

The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent atrial fibrillation over time.

Conditions

Interventions

PROCEDURE

Bipolar radiofrequency ablation

Ablation using CE marked bipolar ablation devices

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • Haukeland Sykehus HF

    collaborator UNKNOWN

  • Ullevaal University Hospital

    collaborator OTHER

  • Regionssykehuset i Tromsø HF

    collaborator UNKNOWN

  • Feiringklinikken

    collaborator UNKNOWN

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Alexander Wahba, Prof · Norwegian University of Science and Technology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2010-06-30
Completion
2012-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184249 on ClinicalTrials.gov